Skip to main content
. 2021 Jul 18;18:150. doi: 10.1186/s12978-021-01189-6

Table 1.

Percent of respondents currently using each method, among 15–24 year-olds and 25–49 year-olds who ever had sex

Among total sample Among current contraceptive users
15–24 (N = 1039) 25–49 (N = 3100) p-val 15–24 (N = 330) 25–49 (N = 946) p-val
Any method 31.9 30.4 0.00 NA NA NA
Female sterilization (tubal ligation)a 0.0 1.4 0.00 0.0 4.7 0.00
Hormonal/LARC methods requiring clinic visit
 Implant 6.3 7.2 0.39 19.8 23.8 0.19
 IUD 0.3 0.9 0.28 0.9 3.0 0.25
 Injectable (3-month) 6.2 6.4 0.87 19.4 20.9 0.63
 Injectable (1-month) 0.4 0.8 0.36 1.4 2.5 0.31
Hormonal methods not requiring clinic visit
 Pill 4.4 4.4 0.98 13.8 14.5 0.76
 Emergency contraception 4.9 1.8 0.00 15.5 5.8 0.00
Condomsb 7.0 2.4 0.00 22.1 7.9 0.00
Modern FABMsc
 LAM 0.2 0.4 0.55 0.8 1.2 0.51
 Standard days Method/CycleBeads 1.6 2.0 0.54 5.0 6.4 0.44
Traditional methods
 Rhythm 4.7 3.9 0.30 14.9 12.8 0.43
 Withdrawal 6.5 2.9 0.00 20.4 9.6 0.00
 Washing 0.9 0.7 0.59 2.8 2.3 0.65
 Other traditional 0.4 1.2 0.13 1.3 4.0 0.11
N-tabletd 1.7 0.8 0.02 5.3 2.6 0.02

All Ns are unweighted. Method prevalence among contraceptive users can add up to > 100% because women can use multiple methods

aMale sterilization was not reported by any respondent

bIncludes female condom users (N = 5 current total users)

cFABM: fertility awareness-based method

d“N-tablet” or Primolut N is a pill containing 5 mg of synthetic progesterone, intended for use in regulating menstrual cycles, dysmenorrhea, or endometriosis. In Ghana, N-tablet is sometimes misused as contraception or emergency contraception